GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » EBITDA Margin %

RushNet (RushNet) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is RushNet EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. RushNet's EBITDA for the three months ended in . 20 was $0.00 Mil. RushNet's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, RushNet's EBITDA margin for the quarter that ended in . 20 was 0.00%.


RushNet EBITDA Margin % Historical Data

The historical data trend for RushNet's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet EBITDA Margin % Chart

RushNet Annual Data
Trend
EBITDA Margin %

RushNet Quarterly Data
EBITDA Margin %

Competitive Comparison of RushNet's EBITDA Margin %

For the Diagnostics & Research subindustry, RushNet's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RushNet's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where RushNet's EBITDA Margin % falls into.



RushNet EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

RushNet's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

RushNet's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RushNet  (OTCPK:RSHN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


RushNet EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of RushNet's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RushNet (RushNet) Business Description

Traded in Other Exchanges
N/A
Address
8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.